Literature DB >> 24636418

Determination of energy metabolites in cancer cells by porous graphitic carbon liquid chromatography electrospray ionization mass spectrometry for the assessment of energy metabolism.

Norbert Szoboszlai1, Xinghua Guo2, Olivér Ozohanics3, Júlia Oláh4, Ágnes Gömöry3, Victor G Mihucz5, András Jeney4, Károly Vékey3.   

Abstract

A high performance liquid chromatography (HPLC) tandem mass spectrometric (MS/MS) method has been developed for the simultaneous determination of fifteen glucose, or acetate derived metabolites isolated from tumor cells. Glycolytic and tricarboxylic acid (TCA) cycle metabolites as well as acidic amino acids were separated on a HPLC porous graphitic carbon (PGC) column and simultaneously determined by means of triple quadrupole MS/MS using multiple reaction monitoring (MRM). Target compounds were eluted within 10 min with 8% v/v formic acid as an electronic modifier added to a 4:1 v/v methanol water mobile phase. The calibration is linear in the 1-100 μM concentration range for each analyte. The limit of detection ranges between 0.39 and 2.78 μM for the analytes concerned. To test the PGC-HPLC-MS/MS method in metabolomic studies, ZR-75.1 human mammary adenocarcinoma cells were labeled with U-(13)C glucose or 1-(13)C acetate. Applying the MRM mode, the incorporation of (13)C into metabolites, isolated from the tumor cells, and derived from glucose or acetate, could be properly identified.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electrospray ionization; Intracellular; Tandem mass spectrometry; Targeted metabolomics; Triple quadrupole

Mesh:

Substances:

Year:  2014        PMID: 24636418     DOI: 10.1016/j.aca.2014.01.055

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  6 in total

1.  Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells.

Authors:  A Jeney; Z Hujber; N Szoboszlai; A Fullár; J Oláh; É Pap; Á Márk; Cs Kriston; J Kralovánszky; I Kovalszky; K Vékey; A Sebestyén
Journal:  Cancer Cell Int       Date:  2016-02-11       Impact factor: 5.722

2.  Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.

Authors:  Nam Hee Kim; Yong Hoon Cha; Jueun Lee; Seon-Hyeong Lee; Ji Hye Yang; Jun Seop Yun; Eunae Sandra Cho; Xianglan Zhang; Miso Nam; Nami Kim; Young-Su Yuk; So Young Cha; Yoonmi Lee; Joo Kyung Ryu; Sunghyouk Park; Jae-Ho Cheong; Sang Won Kang; Soo-Youl Kim; Geum-Sook Hwang; Jong In Yook; Hyun Sil Kim
Journal:  Nat Commun       Date:  2017-02-08       Impact factor: 14.919

3.  GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas.

Authors:  Zoltán Hujber; Gergő Horváth; Gábor Petővári; Ildikó Krencz; Titanilla Dankó; Katalin Mészáros; Hajnalka Rajnai; Norbert Szoboszlai; William P J Leenders; András Jeney; László Tretter; Anna Sebestyén
Journal:  J Exp Clin Cancer Res       Date:  2018-11-07

4.  Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells.

Authors:  Gábor Petővári; Zoltán Hujber; Ildikó Krencz; Titanilla Dankó; Noémi Nagy; Fanni Tóth; Regina Raffay; Katalin Mészáros; Hajnalka Rajnai; Enikő Vetlényi; Krisztina Takács-Vellai; András Jeney; Anna Sebestyén
Journal:  Cancer Cell Int       Date:  2018-12-19       Impact factor: 5.722

5.  Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells.

Authors:  Zoltán Hujber; Gábor Petővári; Norbert Szoboszlai; Titanilla Dankó; Noémi Nagy; Csilla Kriston; Ildikó Krencz; Sándor Paku; Olivér Ozohanics; László Drahos; András Jeney; Anna Sebestyén
Journal:  J Exp Clin Cancer Res       Date:  2017-06-02

6.  Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas.

Authors:  Balazs Sarkadi; Katalin Meszaros; Ildiko Krencz; Letizia Canu; Lilla Krokker; Sara Zakarias; Gabor Barna; Anna Sebestyen; Judit Papay; Zoltan Hujber; Henriett Butz; Otto Darvasi; Peter Igaz; Judit Doczi; Michaela Luconi; Christos Chinopoulos; Attila Patocs
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.